Financhill
Sell
48

KVHI Quote, Financials, Valuation and Earnings

Last price:
$5.39
Seasonality move :
5.86%
Day range:
$5.16 - $5.48
52-week range:
$4.17 - $6.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.88x
P/B ratio:
0.75x
Volume:
30K
Avg. volume:
62.6K
1-year change:
6.92%
Market cap:
$107.1M
Revenue:
$132.4M
EPS (TTM):
-$0.98
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $157.9M $158.7M $133.9M $138.8M $132.4M
Revenue Growth (YoY) 3.18% 0.53% -15.64% 3.61% -4.59%
 
Cost of Revenues $104.1M $101.1M $88.1M $86.3M $94.5M
Gross Profit $53.8M $57.6M $45.8M $52.5M $37.9M
Gross Profit Margin 34.04% 36.29% 34.22% 37.84% 28.61%
 
R&D Expenses $15.9M $15.8M $11.1M $10.4M $9.4M
Selling, General & Admin $58.9M $54.3M $54.3M $47.9M $39.8M
Other Inc / (Exp) $101K -$10.3M $7.1M $772K -$7.4M
Operating Expenses $74.8M $70.1M $65.4M $58.2M $49.2M
Operating Income -$21.1M -$12.4M -$19.6M -$5.7M -$11.4M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$20M -$21.8M -$11.7M -$3.4M -$15.1M
Earnings of Discontinued Ops. $49.3M -- $1.8M $28M --
Income Tax Expense -$4M $174K -$108K $546K $318K
Net Income to Company $33.3M -$21.9M -$9.8M $24M -$15.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $33.3M -$21.9M -$9.8M $24M -$15.4M
 
Basic EPS (Cont. Ops) $1.90 -$1.24 -$0.54 $1.29 -$0.81
Diluted EPS (Cont. Ops) $1.90 -$1.24 -$0.54 $1.29 -$0.81
Weighted Average Basic Share $17.5M $17.7M $18.2M $18.6M $19.1M
Weighted Average Diluted Share $17.5M $17.7M $18.2M $18.6M $19.1M
 
EBITDA -$7.5M -$10.1M $3M $10M -$1.7M
EBIT -$19M -$21.7M -$11.6M -$3.4M -$15.1M
 
Revenue (Reported) $157.9M $158.7M $133.9M $138.8M $132.4M
Operating Income (Reported) -$21.1M -$12.4M -$19.6M -$5.7M -$11.4M
Operating Income (Adjusted) -$19M -$21.7M -$11.6M -$3.4M -$15.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $41.1M $34.4M $35.2M $33.2M $29M
Revenue Growth (YoY) 4.58% -16.36% 2.27% -5.61% -12.73%
 
Cost of Revenues $25.3M $22.3M $22.1M $20.7M $19.7M
Gross Profit $15.8M $12.1M $13M $12.4M $9.3M
Gross Profit Margin 38.47% 35.24% 37.09% 37.49% 32.01%
 
R&D Expenses $3.5M $2.8M $2.7M $2.4M $1.4M
Selling, General & Admin $12.8M $12.8M $11.3M $9.2M $8.7M
Other Inc / (Exp) -$370K $7M $569K -$6.1M -$921K
Operating Expenses $16.3M $15.7M $14M $11.6M $10.1M
Operating Income -$503K -$3.5M -$971K $840K -$854K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$646K $3.7M -$14K -$4.3M -$1.1M
Earnings of Discontinued Ops. -- $348K $29.7M -- --
Income Tax Expense -$109K $16K $81K $95K $51K
Net Income to Company -$537K $4M $29.6M -$4.4M -$1.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$537K $4M $29.6M -$4.4M -$1.2M
 
Basic EPS (Cont. Ops) -$0.03 $0.22 $1.58 -$0.23 -$0.06
Diluted EPS (Cont. Ops) -$0.03 $0.22 $1.58 -$0.23 -$0.06
Weighted Average Basic Share $17.7M $18.3M $18.7M $19.2M $19.4M
Weighted Average Diluted Share $17.7M $18.6M $18.7M $19.2M $19.4M
 
EBITDA $2.2M $7.5M $3.6M -$1.1M $2.1M
EBIT -$644K $3.7M -$13K -$4.3M -$1.1M
 
Revenue (Reported) $41.1M $34.4M $35.2M $33.2M $29M
Operating Income (Reported) -$503K -$3.5M -$971K $840K -$854K
Operating Income (Adjusted) -$644K $3.7M -$13K -$4.3M -$1.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $157.1M $164.2M $138.1M $136.8M $118.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $100.7M $104M $86.4M $87.3M $89.4M
Gross Profit $56.4M $60.2M $51.7M $49.5M $28.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $15.6M $16M $11.2M $9.4M $8.8M
Selling, General & Admin $55.7M $58M $50.7M $38.8M $39.9M
Other Inc / (Exp) $150K -$5M $2.5M -$7.4M -$2.3M
Operating Expenses $71.3M $74M $61.9M $48.1M $48.7M
Operating Income -$14.9M -$13.8M -$10.2M $1.4M -$19.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$13.6M -$18M -$6.7M -$2.6M -$18.6M
Earnings of Discontinued Ops. -$573K $348K $26.7M -$36K --
Income Tax Expense -$426K -$322K $596K $60K $285K
Net Income to Company -$13.8M -$17.3M $19.4M -$2.7M -$18.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$13.8M -$17.3M $19.4M -$2.7M -$18.9M
 
Basic EPS (Cont. Ops) -$0.78 -$0.96 $1.03 -$0.14 -$0.98
Diluted EPS (Cont. Ops) -$0.78 -$0.96 $1.03 -$0.14 -$0.98
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$2.8M -$3.8M $7.9M $9M -$6.3M
EBIT -$13.6M -$17.9M -$6.7M -$3.8M -$19.9M
 
Revenue (Reported) $157.1M $164.2M $138.1M $136.8M $118.4M
Operating Income (Reported) -$14.9M -$13.8M -$10.2M $1.4M -$19.7M
Operating Income (Adjusted) -$13.6M -$17.9M -$6.7M -$3.8M -$19.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $114.6M $120M $102.9M $100.9M $86.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $74.1M $76.9M $62.9M $63.9M $58.8M
Gross Profit $40.5M $43.1M $40M $37M $28.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $11.7M $11.9M $8.4M $7.4M $6.8M
Selling, General & Admin $40.4M $44.2M $37.9M $28.8M $28.9M
Other Inc / (Exp) $971K $6.2M $1.6M -$6.6M -$1.5M
Operating Expenses $52.1M $56.1M $46.3M $36.2M $35.6M
Operating Income -$11.6M -$13M -$6.3M $843K -$7.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$9.9M -$6.1M -$3.9M -$3.1M -$6.6M
Earnings of Discontinued Ops. -- $348K $28.1M -- --
Income Tax Expense $437K -$59K $645K $159K $126K
Net Income to Company -$10.3M -$5.7M $23.5M -$3.2M -$6.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$10.3M -$5.7M $23.5M -$3.2M -$6.7M
 
Basic EPS (Cont. Ops) -$0.58 -$0.31 $1.25 -$0.17 -$0.34
Diluted EPS (Cont. Ops) -$0.58 -$0.31 $1.25 -$0.17 -$0.34
Weighted Average Basic Share $52.9M $54.5M $55.7M $57.3M $58.1M
Weighted Average Diluted Share $52.9M $54.7M $55.7M $57.5M $58.1M
 
EBITDA -$1.6M $4.7M $6.9M $5.8M $2.4M
EBIT -$9.9M -$6M -$3.9M -$4.3M -$7.8M
 
Revenue (Reported) $114.6M $120M $102.9M $100.9M $86.9M
Operating Income (Reported) -$11.6M -$13M -$6.3M $843K -$7.5M
Operating Income (Adjusted) -$9.9M -$6M -$3.9M -$4.3M -$7.8M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $18.4M $12.6M $11.4M $21.1M $11.3M
Short Term Investments $29.9M $25.1M $13.1M $55.7M $58.5M
Accounts Receivable, Net $32.9M $33.7M $27.8M $27.4M $25.7M
Inventory $23.5M $24.7M $15.8M $22.7M $19M
Prepaid Expenses -- -- -- -- --
Other Current Assets $3.2M $3.9M $2.6M $3.1M $4.3M
Total Current Assets $109.3M $101.1M $87.8M $130M $118.8M
 
Property Plant And Equipment $59.9M $63.2M $56M $55.3M $48.7M
Long-Term Investments -- -- -- -- --
Goodwill $15.4M $6.6M $6.6M $5.3M --
Other Intangibles $4.9M $2.3M $1.3M $404K $1.2M
Other Long-Term Assets $6.4M $7.8M $13.9M $5M $3.6M
Total Assets $199.4M $183.6M $168.8M $196.3M $172.6M
 
Accounts Payable $15M $11.4M $9.5M $20.4M $4.8M
Accrued Expenses $9.9M $8.4M $8M $5.5M $12.5M
Current Portion Of Long-Term Debt -- $5M -- -- --
Current Portion Of Capital Lease Obligations $2.8M $3.8M $1.9M $1.5M $786K
Other Current Liabilities $521K $560K $4.5M $637K $673K
Total Current Liabilities $38.4M $40.8M $33.9M $37.1M $25M
 
Long-Term Debt -- $1.9M -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $49.4M $51.7M $39.8M $37.8M $25.3M
 
Common Stock $194K $199K $203K $206K $211K
Other Common Equity Adj -$2.8M -$3.2M -$3.4M -$4.1M -$4.2M
Common Equity $150M $131.9M $129M $158.4M $147.4M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $150M $131.9M $129M $158.4M $147.4M
 
Total Liabilities and Equity $199.4M $183.6M $168.8M $196.3M $172.6M
Cash and Short Terms $48.3M $37.7M $24.5M $76.7M $69.8M
Total Debt -- $6.9M -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $18.1M $9.9M $14.4M $11.5M $14.4M
Short Term Investments $22.5M $17.1M $55.2M $57.7M $35.4M
Accounts Receivable, Net $31.5M $32M $27.8M $28.2M $24.8M
Inventory $24.7M $24.6M $23.9M $26.4M $25.2M
Prepaid Expenses -- -- -- -- $20.5M
Other Current Assets $3.4M $4.8M $3.4M $4.6M --
Total Current Assets $101.5M $89.5M $125.9M $129.6M $131.7M
 
Property Plant And Equipment $59.7M $63.6M $54.3M $50.6M $31M
Long-Term Investments -- -- -- -- --
Goodwill $15.1M $6.6M $5.2M -- --
Other Intangibles $4.1M $1.5M $467K -- $922K
Other Long-Term Assets $7.9M $6.9M $5.1M $4M $2.9M
Total Assets $191.2M $170.4M $194.3M $187M $166.7M
 
Accounts Payable $11.4M $9.1M $9.6M $3.6M $10.2M
Accrued Expenses $10.3M $9.4M $12.4M $12.3M $6.2M
Current Portion Of Long-Term Debt $3.8M -- -- -- --
Current Portion Of Capital Lease Obligations $1.3M $2M $963K $921K $692K
Other Current Liabilities $561K $604K $624K $693K $733K
Total Current Liabilities $38.7M $32M $34.7M $25.7M $23.6M
 
Long-Term Debt $3.1M -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $50.8M $38.4M $39.7M $29.9M $24M
 
Common Stock $197K $203K $206K $211K $213K
Other Common Equity Adj -$4.3M -$3.3M -$4.7M -$4.2M -$3.9M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $140.5M $132M $154.6M $157M $142.7M
 
Total Liabilities and Equity $191.2M $170.4M $194.3M $187M $166.7M
Cash and Short Terms $40.7M $27M $69.6M $69.2M $49.8M
Total Debt $6.9M -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $33.3M -$21.9M -$9.8M $24M -$15.4M
Depreciation & Amoritzation $11.5M $11.7M $14.6M $13.4M $13.4M
Stock-Based Compensation $4.2M $3.5M $4.1M $3.4M $2.1M
Change in Accounts Receivable -$4.3M -$1.1M -$506K $506K $1.7M
Change in Inventories -$553K -$1.2M $33K -$8.5M $3.7M
Cash From Operations -$14.2M -$3.1M $2.9M $8.9M $2.5M
 
Capital Expenditures $12.6M $14.1M $18.8M $14.4M $11.9M
Cash Acquisitions $88.4M -- -- $57.4M --
Cash From Investing $46M -$9.3M -$6.7M $375K -$14.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $10M $6.9M -- -- --
Long-Term Debt Repaid -$40.2M -$624K -$294K -$264K -$22K
Repurchase of Common Stock -$1.3M -$390K -- -- -$239K
Other Financing Activities -- -- -- -- --
Cash From Financing -$30.8M $7.1M $2.6M $708K $2.3M
 
Beginning Cash (CF) $18.1M $18.4M $12.6M $11.4M $21.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.1M -$5.2M -$1.2M $10M -$9.8M
Ending Cash (CF) $18.4M $12.6M $11.4M $21.1M $11.3M
 
Levered Free Cash Flow -$26.8M -$17.2M -$15.9M -$5.6M -$9.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$537K $4M $29.6M -$4.4M -$1.2M
Depreciation & Amoritzation $2.9M $3.8M $3.6M $3.2M $3.3M
Stock-Based Compensation $912K $1M $1.1M $559K $385K
Change in Accounts Receivable -$2.9M $768K $523K -$1.1M $2.7M
Change in Inventories -$205K -$2.3M -$3.3M -$2.2M -$2.5M
Cash From Operations -$42K -$2.9M $1.8M $508K $1.9M
 
Capital Expenditures $3.2M $4.7M $3M $2.4M $1.5M
Cash Acquisitions -- -- $55M -- --
Cash From Investing -$3.2M $3.3M $2M -$3.2M $2.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$156K -$66K -$66K -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$156K $307K $397K $237K --
 
Beginning Cash (CF) $21.4M $9.2M $10.4M $14M $10.4M
Foreign Exchange Rate Adjustment $83K -$15K -$126K -$87K $96K
Additions / Reductions -$3.4M $672K $4.1M -$2.4M $3.9M
Ending Cash (CF) $18.1M $9.9M $14.4M $11.5M $14.4M
 
Levered Free Cash Flow -$3.2M -$7.6M -$1.2M -$1.9M $409K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$13.8M -$17.3M $19.4M -$2.7M -$18.9M
Depreciation & Amoritzation $10.9M $14.2M $14.6M $12.8M $13.6M
Stock-Based Compensation $3.6M $4M $3.8M $2.2M $2.3M
Change in Accounts Receivable -$1.9M -$781K -$1.8M $30K $3.2M
Change in Inventories $661K $27K -$9.6M -$2.5M $1.2M
Cash From Operations -$5.6M $1.8M -$472K $7.7M -$8.4M
 
Capital Expenditures $13.5M $19.2M $14.6M $10.6M $11.3M
Cash Acquisitions -- -- $57.4M -- --
Cash From Investing $10.4M -$13.6M $4.8M -$13.1M $11M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$635K -$384K -$264K -$88K --
Repurchase of Common Stock -$1.7M -- -- -$239K --
Other Financing Activities -- -- -- -- --
Cash From Financing $5M $3.5M $625K $2.5M $96K
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $9.7M -$8.4M $4.9M -$3M $2.7M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$19.1M -$17.4M -$15M -$2.9M -$19.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$10.3M -$5.7M $23.5M -$3.2M -$6.7M
Depreciation & Amoritzation $8.3M $10.8M $10.8M $10.1M $10.3M
Stock-Based Compensation $2.5M $3M $2.7M $1.4M $1.6M
Change in Accounts Receivable $852K $1.2M -$117K -$593K $896K
Change in Inventories -$1.2M $34K -$9.6M -$3.7M -$6.2M
Cash From Operations -$2.9M $1.9M -$1.5M -$2.7M -$13.6M
 
Capital Expenditures $10.3M $15.3M $11M $7.2M $6.6M
Cash Acquisitions -- -- $57.4M -- --
Cash From Investing -$2.9M -$7.2M $4.3M -$9.2M $16.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $6.9M -- -- -- --
Long-Term Debt Repaid -$468K -$228K -$198K -$22K --
Repurchase of Common Stock -$390K -- -- -$239K --
Other Financing Activities -- -- -- -- --
Cash From Financing $6.3M $2.6M $598K $2.3M $96K
 
Beginning Cash (CF) $58.4M $35.8M $29.8M $47.4M $33.1M
Foreign Exchange Rate Adjustment -$711K -$39K -$402K -$13K $72K
Additions / Reductions $495K -$2.7M $3.4M -$9.6M $3M
Ending Cash (CF) $58.1M $33.1M $32.8M $37.9M $36.2M
 
Levered Free Cash Flow -$13.2M -$13.4M -$12.5M -$9.9M -$20.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock